IGFBP7 and glioblastoma: In a glioblastoma multiforme (GBM) mice model and in ex vivo human GBM tissue, IRDyeCy5.5-labelled anti-IGFBP7 VHHs did bind to GBM vessels at 10 min to 24 h after injection, but did not to normal brain vessels (67).